News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
Unitree Robotics Reportedly Wraps up Series C Financing with Pre-Money Valuation Over RMB10B
Humanoid robot company Hangzhou Yushu Technology (Unitree Robotics) recently completed its Series C financing, which began at the end of last year, according to hearsay. The financ...
Reset
Send
The window will close in 5 seconds
Unitree Robotics Reportedly Wraps up Series C Financing with Pre-Money Valuation Over RMB10B
Close
Recommend
29
Positive
37
Negative
7
 
SHORT SELL
 
STOCK INFO

Humanoid robot company Hangzhou Yushu Technology (Unitree Robotics) recently completed its Series C financing, which began at the end of last year, according to hearsay.

The financing was indeed completed recently, according to sources familiar with Unitree Robotics' financing matters, as cited by Sina Tech.

Related NewsHSBC Global Research Envisions Continued Div. Growth for CN Telecoms; Top Pick CHINA MOBILE
The Series C financing was jointly led by CHINA MOBILE (00941.HK)  +0.600 (+0.699%)    Short selling $159.18M; Ratio 13.031%   's fund, TENCENT (00700.HK)  +7.500 (+1.506%)    Short selling $2.17B; Ratio 20.960%   , BABA-W (09988.HK)  +1.700 (+1.545%)    Short selling $3.21B; Ratio 26.960%   , Ant Group, and Geely Capital, with most of Unitree's existing shareholders participating. Unitree's pre-money valuation currently exceeds RMB10 billion.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-06-20 16:25.)

AASTOCKS Financial News
Website: www.aastocks.com
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.